| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/20/1998 | US5709848 Photocleavable metal-chelating agents and compositions containing the same |
| 01/15/1998 | WO1998001145A1 Therapeutic applications of t-bam (cd40l) technology to treat diseases involving smooth muscle cells |
| 01/15/1998 | WO1998001124A2 Pharmaceutical preparation containing nimesulide for topical use |
| 01/15/1998 | CA2207141A1 Benzothiophene compounds, and uses and formulations thereof |
| 01/15/1998 | CA2207083A1 Benzothiophene compounds, and uses and formulations thereof |
| 01/14/1998 | EP0818201A1 Use of a polysaccharide to stimulate immune defenses |
| 01/14/1998 | EP0818200A1 Use of polysaccharide to stimulate desquamation of the skin and compositions containing it |
| 01/14/1998 | EP0817775A1 Quinazoline derivatives |
| 01/14/1998 | EP0817641A1 Substances extracted from dictyotales, preparation method therefor, and compositions containing same |
| 01/14/1998 | EP0817628A2 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 01/14/1998 | EP0817627A1 Protein kinase c inhibitors |
| 01/14/1998 | EP0817625A2 Compositions for treatment of photodamaged skin comprising an rar-alpha antagonist and a multi-selective retinoid |
| 01/14/1998 | EP0533865B1 Peat-derived bioactive products and pharmaceutical and cosmetic compositions containing them |
| 01/14/1998 | CN1169863A Chinese medicine preparation for sore, ulcer and infection caused by external wound and preparation method |
| 01/13/1998 | US5708028 Use of Cis-9-heptadecenoic acid for treating psoriasis and allergies |
| 01/13/1998 | US5707989 Pyrimido 5,4-D!pyrimidines, medicaments comprising these compounds, their use and processes for their preparation |
| 01/13/1998 | US5707978 Antitumor agents, psoriasis, antiinflammatory agents |
| 01/13/1998 | US5707972 Polysaccharides and anesthetics and/or microbiocides for wound healing agents |
| 01/13/1998 | US5707805 Assay for detecting keratinocyte growth factor (KGF) and its activity |
| 01/13/1998 | US5707635 Containing a crosslinked polyacrylamide-type polymer and an active compound, optionally a humectant and an emollient |
| 01/13/1998 | US5707627 Methods and compositions for the direct concentrated delivery of passive immunity |
| 01/13/1998 | US5706944 Non-aqueous emollient iodophor formulations |
| 01/08/1998 | WO1998000168A1 Topical composition comprising a combination of antihistaminic compounds with terpenoid compounds |
| 01/08/1998 | WO1998000145A1 Topical administration of certain azaspiranes to prevent or treat skin conditions associated with hyperproliferation of skin cells and/or immunologically mediated disorders |
| 01/08/1998 | WO1998000129A2 Anticonvulsant derivatives useful in treating psoriasis |
| 01/08/1998 | WO1998000127A1 Retinoyloxy(substituted)alkylene butyrates useful for the treatment of cancer and other proliferative diseases |
| 01/08/1998 | WO1998000095A1 Isolated arachidonic acid-binding heteromer and its use in cosmetics and pharmaceutics |
| 01/08/1998 | WO1998000025A1 Aquatic animal treatment method and composition containing cajeput oil |
| 01/08/1998 | WO1997041824A3 Antiangiogenic peptides derived from plasminogen |
| 01/08/1998 | WO1997033995A3 Extracellular matrix signalling molecules |
| 01/08/1998 | CA2258796A1 Isolated arachidonic acid-binding heteromer and its use in cosmetics and pharmaceutics |
| 01/08/1998 | CA2258593A1 Retinoyloxy(substituted)alkylene butyrates useful for the treatment of cancer and other proliferative diseases |
| 01/08/1998 | CA2258513A1 Topical composition comprising a combination of antihistaminic compounds with terpenoid compounds |
| 01/07/1998 | EP0816497A2 Human requiem polypeptide for apoptosis |
| 01/07/1998 | EP0816357A1 Substituted indazole derivatives |
| 01/07/1998 | EP0816352A1 Bi-aryl heterocyclic compounds and their use in human or veterinary medicine and in cosmetics |
| 01/07/1998 | EP0816324A1 Subsituted benzyl derivatives of polyalkylene-polyamines and their use in cosmetic and pharmaceutical compositions |
| 01/07/1998 | EP0815860A2 Terfenadine carboxylate and the treatment of allergic disorders |
| 01/07/1998 | EP0815845A1 Cosmetic and/or dermatological acidic composition containing a crosslinked and at least 90% neutralized polymer of 2-acrylamide-2-methylpropane sulfonic acid |
| 01/07/1998 | EP0815840A2 Method for the treatment or prevention of intrinsically aged skin with retinoids |
| 01/07/1998 | EP0815838A2 External skin treatment composition |
| 01/07/1998 | EP0815755A1 Cyclist helmet with stabilizing strap |
| 01/07/1998 | EP0815237A1 Threonyl-trna synthetase of staphylococcus aureus |
| 01/07/1998 | EP0815223A1 Dermatomyositis-specific auto-antigen |
| 01/07/1998 | EP0815218A2 Human vegf-specific antisense oligonucleotides |
| 01/07/1998 | EP0815211A1 New defined enzyme mixtures for obtaining cells and treating wounds |
| 01/07/1998 | EP0815144A1 Process for glucan preparation and therapeutic uses of glucan |
| 01/07/1998 | EP0815115A1 Keratinocyte growth factor-2 |
| 01/07/1998 | EP0815087A1 Trisubstituted phenyl derivatives |
| 01/07/1998 | EP0815084A1 Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease |
| 01/07/1998 | EP0814837A1 Use of g class immunoglobulins for the topical treatment of atopic dermatitis |
| 01/07/1998 | EP0814815A1 Poly(hydroxy acid)/polymer conjugates for skin applications |
| 01/07/1998 | EP0814800A1 Water-based topical cream containing nitroglycerin; method of preparation and use thereof |
| 01/07/1998 | EP0814776A1 Topically applied pharmaceutical composition, method of preparing it and its use |
| 01/07/1998 | EP0814763A1 Depigmenting dermatological and/or cosmetic composition |
| 01/07/1998 | EP0814660A1 Topical antimicrobial agents |
| 01/07/1998 | EP0716609A4 METHODS AND COMPOSITIONS FOR STIMULATING AND INHIBITING TGF--g(b) ACTIVITY |
| 01/07/1998 | EP0584062B1 Method and composition for treating hyperproliferative skin diseases using 6-aminopurine cytokinins |
| 01/07/1998 | EP0464175B1 Extracellular form of the human fibroblast growth factor receptor |
| 01/07/1998 | CN1169425A Fluorinated vitamin D3 analogs |
| 01/07/1998 | CN1169297A Medicine for external use for treatment of psoriasis |
| 01/07/1998 | CN1169296A Medicine for external use for treatment of alopecia areata |
| 01/07/1998 | CN1169295A Preparation for theatment of alopecia areata |
| 01/07/1998 | CN1036920C Heterocycle-containing carbonic acid derivatives |
| 01/06/1998 | US5705525 Thiophene compounds |
| 01/06/1998 | US5705511 Fused pyrrolocarbazoles |
| 01/06/1998 | US5705504 Platelet activating factor |
| 01/06/1998 | US5705494 Anti-estrogenic activity of IIβ-substituted-19-NOR Steroids |
| 01/06/1998 | US5705485 Gel formulations containing growth factors |
| 01/06/1998 | US5705180 Therapeutic agent for the treatment of melanomas |
| 01/06/1998 | US5705177 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 01/06/1998 | US5705168 Lactic acid for skin disorders |
| 01/06/1998 | US5705167 Treatment of dermatological, rheumatic, respiratory, cardiovascular, bone and ophthalmological disorders |
| 01/06/1998 | US5704072 Occipital retention strap for cyclist headgear |
| 01/06/1998 | CA2183686A1 Cyclist helmet with stabilizing strap |
| 12/31/1997 | WO1997049827A2 Adenoviral mediated gene transfer in adipocytes and related implants |
| 12/31/1997 | WO1997049704A1 N-[4-(heteroarylmethyl)phenyl]-heteroarylamines |
| 12/31/1997 | WO1997049702A1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors |
| 12/31/1997 | WO1997049680A1 Il-8 receptor antagonists |
| 12/31/1997 | WO1997049408A1 The use of growth factor modulating compounds |
| 12/31/1997 | WO1997049406A1 Use of k-252a derivative for the treatment of peripheral or central nerve disorders, and cytokine overproduction |
| 12/31/1997 | WO1997049383A1 Antibacterial composition |
| 12/31/1997 | WO1997049286A1 Il-8 receptor antagonists |
| 12/31/1997 | CN1169158A Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
| 12/31/1997 | CN1168800A Ointment for skin-protection after being burned |
| 12/31/1997 | CA2259228A1 Adenoviral mediated gene transfer in adipocytes and related implants |
| 12/31/1997 | CA2258850A1 Il-8 receptor antagonists |
| 12/30/1997 | US5703230 Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same |
| 12/30/1997 | US5703043 Bone morphogenetic protein-10 (BMP-10) compositions |
| 12/30/1997 | US5702720 Involving an acrylate or mathacrylate based copolymer, a skin penetration enhancer, a polyvinylpyrrolidone polymer and flurbiprofen drug; antiinflamatory, analgesic and antipyretic agent |
| 12/30/1997 | US5702711 Method for enhancing the rate of skin permeation of lactic acid through use of the L-enantiomer |
| 12/29/1997 | EP0814080A1 Squalene synthetase inhibitors |
| 12/29/1997 | EP0813875A2 Inhibition of abnormal accumulation of extracellular matrices |
| 12/29/1997 | EP0813520A1 Arylsulfonylamino hydroxamic acid derivatives |
| 12/29/1997 | EP0813418A2 Composition for treating skin conditions comprising an inhibitor of skin iso-phosphodiesterase |
| 12/29/1997 | EP0813405A1 Polypodium extract as photoprotectant |
| 12/29/1997 | EP0750604B1 A method of rendering organic compounds soluble in fatty systems, novel chemical complexes of such compounds and various applications of the complexes |
| 12/28/1997 | CA2209430A1 Cosmetic and/or dermatological acid composition containing one cross-linked poly(2-acrylamido 2-methylpropane sulfonic acid) polymer neutralized to at least 90% |
| 12/24/1997 | WO1997048697A1 Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
| 12/24/1997 | WO1997048693A1 Isocoumarin derivatives and use thereof in drugs |